CVS Health, San Francisco, CA.
Mays Cancer Center at UT Health San Antonio, San Antonio, TX.
Ethn Dis. 2022 Jan 20;32(1):61-68. doi: 10.18865/ed.32.1.61. eCollection 2022 Winter.
Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-person committee dedicated to developing strategies to increase clinical research participation. To help improve the recruitment and retention of patients of color, this article chronicles our efforts to tangibly address the clinical research barriers at the system, study, and patient levels over the last four years. These efforts are one of the initial steps to fully realize the promise of personalized health care and provide increased patient benefit at less cost to society. Instead of simply acknowledging the problem, here we illuminate the collaborative and multilevel strategies that have been effective in delivering meaningful progress for patients.
临床研究中特征明显的差异不成比例地影响了有色人种患者，尤其是在服务不足的社区。为了克服这些障碍，罗氏成立了外部推进包容性研究理事会，这是一个由 14 人组成的委员会，致力于制定增加临床研究参与的策略。为了帮助提高有色人种患者的招募和保留率，本文记录了我们在过去四年中在系统、研究和患者层面上为切实解决临床研究障碍所做的努力。这些努力是充分实现个性化医疗保健承诺并以更低的社会成本为患者带来更多益处的初始步骤之一。在这里，我们没有简单地承认这个问题，而是阐明了在为患者带来有意义的进展方面行之有效的协作和多层次策略。
